Form 4: Merck Executive Oosthuizen Reports Stock Transactions

Johannes Oosthuizen, a Merck executive, reports the vesting and distribution of restricted stock units and subsequent stock transactions.

Summary

• Johannes Oosthuizen, President, U.S. Market at Merck & Co., Inc., reported transactions involving Merck common stock on February 8, 2025.
• Restricted stock units vested and were distributed as shares of Merck common stock.
• 13,002 shares were acquired upon vesting of restricted stock units at a price of $87.28.
• 6,404 shares were disposed of to cover tax obligations at a price of $87.28.
• Following these transactions, Oosthuizen beneficially owns 39,205.474 shares of Merck common stock directly.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock transactions, and does not inherently convey positive or negative sentiment. It's a neutral disclosure.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency to investors regarding insider activity.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they represent routine executive compensation activities.

Key Dates

Keywords

Merck, Oosthuizen, Stock, Restricted Stock Units, Form 4, SEC, Beneficial Ownership, Transactions